Adaptive Biotechnologies Corp. Tech Stack

Immune profiling platform for cancer, autoimmune, and infectious disease diagnostics

Biotechnology Seattle, Washington 501–1,000 employees Founded 2009 Public Company

Adaptive Biotechnologies operates an immune profiling platform that sequences and analyzes adaptive immune responses to guide disease diagnosis and treatment. The tech stack reveals a healthcare-infrastructure-first organization: Epic, Cerner, and Athena EHRs dominate, paired with HL7/FHIR standards, diagnostic LIMS, and modern DevOps (Kubernetes, Terraform, Azure). The active project list—EMR integrations, go-live readiness, payer contracting, assay prototyping—maps directly to pain points around adoption bottlenecks and healthcare system entry, suggesting the company is in a critical transition from R&D to commercial diagnostics delivery.

Tech Stack 33 technologies

Core StackEpic Systems GitLab Docker Postman Kubernetes Terraform Python GitHub Copilot Linux Java C# React TypeScript VMware Cerner Athena HL7 FHIR JFrog LaunchDarkly Bash Camunda ChatGPT Azure SQL Vaisala LIMS Microsoft 365 Word Excel+2 more

What Adaptive Biotechnologies Corp. Is Building

◆Challenges

Integration of diagnostic assay into healthcare settings
Emr integration
Accelerating adoption
Expanding patient access to diagnostics
Cost control and optimization
Driving adoption with payers
Maintaining system integrity and availability
Remediating vulnerabilities
Integrating emr and lis systems
Ensuring secure connectivity

▲Active Projects

Design and implementation of tailored diagnostic workflows
Implementing go-live readiness for diagnostic integrations
Deep learning models for tcr–pmhc specificity prediction
Support emr integration efforts
Coverage and contracting strategies with payers
Develop assay prototypes to commercial products
Equipment and automation development lifecycles
Continuous improvement initiatives for lab processes
Fee-for-service offerings
Strategic partnerships

Hiring Activity

Decelerating30 roles · 7 in 30d

Department

Engineering

Ops

Sales

Healthcare

Data

Product

Seniority

Senior

Mid

Manager

Director

Junior

Principal

Notable leadership hires: Director

Company intelligence

Find more companies like Adaptive Biotechnologies Corp. by tech stack, pain points and active projects

Get started free

About Adaptive Biotechnologies Corp.

Adaptive Biotechnologies develops an immune profiling platform that sequences T-cell receptors and predicts immune responses to enable precision diagnostics and therapeutics. Founded in 2009 and headquartered in Seattle, the company operates at the intersection of immunology research, clinical diagnostics, and therapeutic development. The organization spans 501–1,000 employees across engineering, operations, sales, healthcare, data, and product functions. Active work focuses on integrating diagnostic workflows into hospital and clinic EMR systems, developing assay prototypes for commercial launch, and securing payer coverage agreements to drive patient access.

HeadquartersSeattle, Washington

Company Size501–1,000 employees

Founded2009

Hiring MarketsUnited States, France

Frequently Asked Questions

What is Adaptive Biotechnologies' tech stack?

Core platforms: Epic, Cerner, Athena EHRs; HL7/FHIR standards; diagnostic LIMS. Development: Python, Java, C#, TypeScript, React, Linux, Kubernetes, Terraform, Azure. DevOps: GitLab, Docker, JFrog, Postman. AI/automation: deep learning models, ChatGPT, GitHub Copilot, Camunda workflow engine.

What is Adaptive Biotechnologies working on?

Primary initiatives: EMR integration and go-live readiness for diagnostic workflows; deep learning models for immune-response prediction; assay prototype development; payer contracting and coverage strategies; lab automation and process improvement; fee-for-service diagnostic offerings.